Selank in Cognitive Research: A Look at the Russian Peptide Drawing Renewed Interest
Among the synthetic peptides drawing renewed research attention in 2026, Selank occupies a distinctive position. Developed at the Russian Academy of Sciences in the 1990s as a synthetic analog of the endogenous immunomodulatory peptide tuftsin, Selank was originally investigated for its anxiolytic properties. The intervening decades have seen its research profile expand into cognitive, immunological,…